Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 8586006 Organ-specific proteins and methods of their use
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
August 9, 2007
0
Date of Patent
November 19, 2013
0
Patent Application Number
12376951
0
Patent Citations Received
US Patent 12065466 Methods and compositions for protein sequencing
0
US Patent 12012441 Engineered human IL-21 cytokines and methods for using the same
0
US Patent 12060611 Gene expression profiles associated with sub-clinical kidney transplant rejection
0
US Patent 11654193 Cancer treatment combinations
0
US Patent 11673915 DEPDC1-derived peptide and vaccine containing same
0
US Patent 11684657 HLA-restricted VGLL1 peptides and use thereof in promoting an immune response in a subject
0
US Patent 11826410 Peptides and combination of peptides for use in immunotherapy against various cancers
0
US Patent 11833194 Peptides and combination of peptides for use in immunotherapy against various cancers
0
US Patent 11959920 Methods and compositions for protein sequencing
0
US Patent 11958885 Methods for determining a rapid progression rate of amyotrophic lateral sclerosis (ALS) and restoring phagocytic function of microglia thereof using a NCK-associated protein 1 (NCKAP1) protein or an mRNA thereof
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
8586006
0
Patent Primary Examiner
D. L. Jones
0
Find more entities like US Patent 8586006 Organ-specific proteins and methods of their use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE